Skip to main content
. 2017 Apr 4;18:22. doi: 10.1186/s40360-017-0124-y

Table 3.

Treatment adherence outcomes in patients with acromegaly receiving octreotide or lanreotide with 180-day washout period

Treatment N Variable N Mean SE Minimum Maximum
Octreotide 545 Treatment time (days) 545 254.7 14.5 0 1563
Number of injections 545 7.21 0.4 1 63
MPR (%) 389 89 3 0.06 10
Lanreotide 118 Treatment time (days) 118 351.8 34.2 0 1454
Number of injections 118 10.2 0.9 1 49
MPR (%) 99 87 4 0.13 3.8

N sample size, SE standard error, MPR medication possession ratio